000 01303 a2200373 4500
005 20250515030419.0
264 0 _c20060706
008 200607s 0 0 eng d
022 _a0004-3591
024 7 _a10.1002/art.21987
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBirnbaum, Belinda
245 0 0 _aFulminating hydralazine-induced lupus pneumonitis.
_h[electronic resource]
260 _bArthritis and rheumatism
_cJun 2006
300 _a501-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntihypertensive Agents
_xadverse effects
650 0 4 _aFatal Outcome
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydralazine
_xadverse effects
650 0 4 _aLung
_xdrug effects
650 0 4 _aLung Diseases, Interstitial
_xchemically induced
650 0 4 _aLupus Erythematosus, Systemic
_xchemically induced
650 0 4 _aRadiography, Thoracic
650 0 4 _aTomography, X-Ray Computed
700 1 _aSidhu, Gurdip S
700 1 _aSmith, Robert L
700 1 _aPillinger, Michael H
700 1 _aTagoe, Clement E
773 0 _tArthritis and rheumatism
_gvol. 55
_gno. 3
_gp. 501-6
856 4 0 _uhttps://doi.org/10.1002/art.21987
_zAvailable from publisher's website
999 _c16335916
_d16335916